# Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

> **NCT06596018** · PHASE1,PHASE2 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 96 (estimated)

## Conditions studied

- Breast Adenocarcinoma

## Interventions

- **RADIATION:** SBRT
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06596018
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-25
- **Primary completion:** 2027-09-20
- **Final completion:** 2028-09-20
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06596018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06596018, "Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06596018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*